CellSeed (TSE:7776) Change In Payables And Accrued Expense : 円0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is CellSeed Change In Payables And Accrued Expense?

CellSeed's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was 円0.0 Mil. It means CellSeed's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

CellSeed's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was 円0.0 Mil. It means CellSeed's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

CellSeed Change In Payables And Accrued Expense Historical Data

The historical data trend for CellSeed's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSeed Change In Payables And Accrued Expense Chart

CellSeed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

CellSeed Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

CellSeed Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

CellSeed Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of CellSeed's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSeed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSeed Inc (TSE:7776) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Katsura-Bldg, 4F, 3-61, Haramachi, Shinjuku-ku, Tokyo, 162-0053, JPN

Website

http://www.cellseed.com

CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

CellSeed Headlines

No Headlines